摘要
目的探讨肺结核丸辅助治疗空洞型肺结核的临床效果。方法70例空洞型肺结核患者,随机分为对照组与实验组,每组35例。对照组采用传统2HRZE/4HRE治疗方案,实验组在对照组基础上加用肺结核丸辅助治疗。比较两组患者治疗第2、6个月末空洞变化情况。结果治疗第2个月末,实验组空洞闭合率17.14%(6/35)高于对照组的2.86%(1/35),差异有统计学意义(P<0.05)。治疗第6个月末,实验组空洞闭合率80.00%(28/35)高于对照组的51.43%(18/35),差异有统计学意义(P<0.05)。结论在常规抗结核治疗的基础上联合中药肺结核丸治疗空洞型肺结核,有助于肺结核患者空洞的缩小及闭合,疗效显著,可在临床应用。
Objective To unalyzc the clinical effct of Feijiche pills in adjuvant treatment of cavitarypulmonary tuberculosis. Methods A total of 70 patients with cavitary pulmonary tuberculosis were randomlydivided into control group and experimental group, with 35 cases in each group. The control group receivedtraditional 2HRZE/4HRE regimen, while the experimental group was treated with Feijiehe pills on the hasis ofthe control group. The changes of cavities at the end of 2 and 6 months of treatment between the two groups werecompared. Results At the end of 2 months of treatment, the experimental group had highcr cavity closure ratcas 17.14%(6/35) than 2.86%(1/35) in the control group, and the difference was statistically significant (P<0.05).At the end of 6 months of treatment, the experimental group had higher cavity closure rate as 80.00%(28/35) than51.43%(18/35) in the control group, and the difference was statistically significant (P<0.05). Conclusion Onthe basis of traditional anli-lubereulosis therapy, combined with traditional Chinese medicine Feijiehe pills hassignificant efficacy in the treatment of cavitary pulmonary tuherculosis, and it is helpful to narrow and close thecavity of tuberculosis patients. This method can be used in clinical practice.
作者
白迪
王禹
安静
BAI Di;WANG Yu;AN Jing(Yinghou Ilea1th Services Center,Yingkou 115000,China)
出处
《中国实用医药》
2019年第26期94-95,共2页
China Practical Medicine
关键词
肺结核丸
空洞型肺结核
临床疗效
Feijiehe pills
Cavitary pulmonary tuberculosis
Clinical effiacy